Coagulation Factors as Predictive Markers of Poor Outcomes in Children with Acute Liver Failure

Clinical Laboratory
|August 17, 2022
PubMed

Insights

Coagulation factors like Factor VII (FVII) and Factor V (FV), along with INR, effectively predict poor outcomes in children with acute liver failure (ALF). Monitoring these markers alongside liver function tests is crucial for managing ALF.

Area of Science:

  • Pediatric Hepatology
  • Clinical Biochemistry
  • Transplantation Medicine

Background:

  • Acute liver failure (ALF) in children is a critical condition with high mortality, especially when liver transplantation (LT) is not feasible.
  • Predictive markers are essential for managing pediatric ALF and guiding treatment decisions.
  • Current methods include clinical scores and criteria, but the role of specific coagulation factors requires further assessment.

Purpose of the Study:

  • To evaluate the predictive value of coagulation factors (Factor V, Factor VII, INR) for poor outcomes in pediatric ALF.
  • To compare the performance of coagulation factors with established scores (PELD, MELD) and criteria (King's College Hospital, Clichy) in predicting ALF outcomes.

Main Methods:

  • A prospective study of 40 children diagnosed with ALF.
  • Analysis of clinical and laboratory parameters, including plasma levels of Factor V (FV), Factor VII (FVII), and INR.
  • Calculation and assessment of PELD, MELD, King's College Hospital (KCH), and Clichy criteria for predicting poor outcomes (emergency LT or death).

Main Results:

  • Significantly lower FV and FVII levels were observed in children with poor outcomes compared to survivors.
  • Higher maximum INR (INR-max) and PELD/MELD scores were associated with poor outcomes.
  • FVII, FV, and INR-max demonstrated excellent performance in predicting poor outcomes, with high areas under the ROC curve.
  • KCH criteria showed higher sensitivity but lower specificity than Clichy criteria.

Conclusions:

  • Coagulation factors (INR, FV, FVII) are reliable predictive markers for fatal outcomes in pediatric ALF.
  • Monitoring these coagulation parameters is recommended alongside standard liver function tests for comprehensive ALF management.
  • These findings can aid in early identification of high-risk children requiring intensive monitoring or timely intervention.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
55
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
296
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.3K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.6K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
75
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
63